Tevogen Bio Holdings Inc.
TVGN
$0.9364
$0.0323.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -61.68% | -3.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -47.43% | 10.61% | |||
| Operating Income | 47.43% | -10.61% | |||
| Income Before Tax | 46.91% | -9.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 46.91% | -9.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.91% | -9.77% | |||
| EBIT | 47.43% | -10.61% | |||
| EBITDA | 48.11% | -10.65% | |||
| EPS Basic | 53.00% | 26.19% | |||
| Normalized Basic EPS | 53.37% | 27.49% | |||
| EPS Diluted | 56.29% | 20.63% | |||
| Normalized Diluted EPS | 53.37% | 27.49% | |||
| Average Basic Shares Outstanding | 14.19% | 51.29% | |||
| Average Diluted Shares Outstanding | 14.19% | 51.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||